Hi @RaceOncology
Three or more of the nucleoside analogs plus bisantrene gives the highest synergy in preclinical.
IIRC only two nucleoside analogs plus bisantrene are proposed for the Israel trial.
Why only two?
Let me guess, legal reasons.
Ann: Bisantrene Preclinical Drug Study Published, page-3
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.55 |
Change
0.085(5.80%) |
Mkt cap ! $264.2M | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.55 | $1.49 | $246.4K | 163.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.55 | 5483 | 2 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |